Business Context and Reporting Period
This Form 8-K Current Report was filed by QuidelOrtho Corporation on November 19, 2024, with the earliest event reported on that date. The filing primarily addresses a secondary underwritten offering of common stock by a selling stockholder affiliated with The Carlyle Group and the subsequent resignation of two directors.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific transaction:
- Shares Sold: 8,260,183 shares of common stock.
- Offering Price: $35.314 per share.
- Company Proceeds: $0. The Company did not sell any shares and received no proceeds from this transaction.
Material Changes
The filing reports two material changes effective November 21, 2024:
- Board Composition: James R. Prutow and Robert R. Schmidt resigned from the Board of Directors. These resignations were submitted in accordance with the Principal Stockholders Agreement and were not the result of any dispute with the Company.
- Shareholder Structure: The sale of shares by the Selling Stockholder resulted in the termination of the Principal Stockholders Agreement dated December 22, 2021.
Outlook, Risks, and Unusual Items
Transaction Details: The offering was underwritten by Goldman Sachs & Co. LLC. The Company and the Selling Stockholder agreed to indemnify the underwriter against certain liabilities under the Securities Act of 1933.
Risks and Contingencies: The filing notes that the resignations were not due to disagreements regarding operations, policies, or practices. No other risks or contingencies were disclosed in this specific report.
Investor Verification Checklist
- Verify the updated Board of Directors composition following the resignations of Mr. Prutow and Mr. Schmidt.
- Confirm the termination of the Principal Stockholders Agreement with The Carlyle Group.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification obligations.
- Note that this transaction generated no capital for QuidelOrtho Corporation.